← Open Payments lookup

LILIA FRAUSTO: Open Payments

NPI 1518151984 · LOS ANGELES, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$723 in 15 payments from 10 companies in 2025. Trend: 2023 $237 · 2024 $414 · 2025 $723

Food & beverage: $723
CompanyPaymentsAmount
Incyte Corporation3$150
Astellas Pharma US Inc1$126
Syndax Pharmaceuticals, Inc.1$103
Gilead Sciences, Inc.2$79
GENZYME CORPORATION2$69
JAZZ PHARMACEUTICALS INC.1$63
Daiichi Sankyo Inc.2$51
Boston Scientific Corporation1$38
Merck Sharp & Dohme LLC1$23
Takeda Pharmaceuticals U.S.A., Inc.1$22

Products named: Zynyz, Vyloy, Trodelvy, SARCLISA, ZIIHERA, DATROWAY, SpyGlass Discover, KEYTRUDA.

Industry payments across CA — which companies pay providers there.